Stories Tagged as
Biogen
Medicare proposes limiting coverage of controversial Alzheimer's drug
by
Lily Jamali
Jan 13, 2022
Government insurer won't cover Aduhelm's $28,000-a-year price tag except for clinical trials.
Who will end up paying the price for Biogen's new Alzheimer's drug?
Jun 18, 2021
The cost of the newly approved treatment will be about $56,000 a year, much of it paid for by Medicare.